A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration

James T. Handa; Cathy Bowes Rickman; Andrew D. Dick; Michael B. Gorin; Joan W. Miller; Cynthia A. Toth; Marius Ueffing; Marco Zarbin; Lindsay A. Farrer

doi:10.1038/s41467-019-11262-1

A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration

James T. Handa, Cathy Bowes Rickman, Andrew D. Dick, Michael B. Gorin, Joan W. Miller, Cynthia A. Toth, Marius Ueffing, Marco Zarbin, Lindsay A. Farrer

School of Medicine

Research output: Contribution to journal › Article

Abstract

Age-related macular degeneration (AMD) is the most common cause of blindness among the elderly in the developed world. While treatment is effective for the neovascular or “wet” form of AMD, no therapy is successful for the non-neovascular or “dry” form. Here we discuss the current knowledge on dry AMD pathobiology and propose future research directions that would expedite the development of new treatments. In our view, these should emphasize system biology approaches that integrate omic, pharmacological, and clinical data into mathematical models that can predict disease onset and progression, identify biomarkers, establish disease causing mechanisms, and monitor response to therapy.

Original language	English (US)
Article number	3347
Journal	Nature communications
Volume	10
Issue number	1
DOIs	https://doi.org/10.1038/s41467-019-11262-1
State	Published - Dec 1 2019

Fingerprint

ASJC Scopus subject areas

Chemistry(all)
Biochemistry, Genetics and Molecular Biology(all)
Physics and Astronomy(all)

Cite this

Handa, J. T., Bowes Rickman, C., Dick, A. D., Gorin, M. B., Miller, J. W., Toth, C. A., Ueffing, M., Zarbin, M., & Farrer, L. A. (2019). A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration. Nature communications, 10(1), [3347]. https://doi.org/10.1038/s41467-019-11262-1

A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration. / Handa, James T.; Bowes Rickman, Cathy; Dick, Andrew D.; Gorin, Michael B.; Miller, Joan W.; Toth, Cynthia A.; Ueffing, Marius; Zarbin, Marco; Farrer, Lindsay A.

In: Nature communications, Vol. 10, No. 1, 3347, 01.12.2019.

Research output: Contribution to journal › Article

@article{89cb1d57a57648368676c5b196798712,

title = "A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration",

abstract = "Age-related macular degeneration (AMD) is the most common cause of blindness among the elderly in the developed world. While treatment is effective for the neovascular or “wet” form of AMD, no therapy is successful for the non-neovascular or “dry” form. Here we discuss the current knowledge on dry AMD pathobiology and propose future research directions that would expedite the development of new treatments. In our view, these should emphasize system biology approaches that integrate omic, pharmacological, and clinical data into mathematical models that can predict disease onset and progression, identify biomarkers, establish disease causing mechanisms, and monitor response to therapy.",

author = "Handa, {James T.} and {Bowes Rickman}, Cathy and Dick, {Andrew D.} and Gorin, {Michael B.} and Miller, {Joan W.} and Toth, {Cynthia A.} and Marius Ueffing and Marco Zarbin and Farrer, {Lindsay A.}",

year = "2019",

month = dec,

day = "1",

doi = "10.1038/s41467-019-11262-1",

language = "English (US)",

volume = "10",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration

AU - Handa, James T.

AU - Bowes Rickman, Cathy

AU - Dick, Andrew D.

AU - Gorin, Michael B.

AU - Miller, Joan W.

AU - Toth, Cynthia A.

AU - Ueffing, Marius

AU - Zarbin, Marco

AU - Farrer, Lindsay A.

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Age-related macular degeneration (AMD) is the most common cause of blindness among the elderly in the developed world. While treatment is effective for the neovascular or “wet” form of AMD, no therapy is successful for the non-neovascular or “dry” form. Here we discuss the current knowledge on dry AMD pathobiology and propose future research directions that would expedite the development of new treatments. In our view, these should emphasize system biology approaches that integrate omic, pharmacological, and clinical data into mathematical models that can predict disease onset and progression, identify biomarkers, establish disease causing mechanisms, and monitor response to therapy.

AB - Age-related macular degeneration (AMD) is the most common cause of blindness among the elderly in the developed world. While treatment is effective for the neovascular or “wet” form of AMD, no therapy is successful for the non-neovascular or “dry” form. Here we discuss the current knowledge on dry AMD pathobiology and propose future research directions that would expedite the development of new treatments. In our view, these should emphasize system biology approaches that integrate omic, pharmacological, and clinical data into mathematical models that can predict disease onset and progression, identify biomarkers, establish disease causing mechanisms, and monitor response to therapy.

UR - http://www.scopus.com/inward/record.url?scp=85069643241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069643241&partnerID=8YFLogxK

U2 - 10.1038/s41467-019-11262-1

DO - 10.1038/s41467-019-11262-1

M3 - Article

C2 - 31350409

AN - SCOPUS:85069643241

VL - 10

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 3347

ER -

Access to Document

10.1038/s41467-019-11262-1